GYNs at the REI gates: unsolvable conundrum or unambiguous opportunity?

Contemporary fertility care has matured from a restricted, special interest in women's health care where success sometimes made magazine covers to a well-honed start-to-finish process with ever-improving success rates and an ever-expanding panoply of treatment options. Innovations in both lab and clinic have been exponential and game changing. The specialty now finds itself in the enviable position of an extensive menu of highly successful treatment options but a complicated set of circumstances of access to these options.

Moonshot. Long shot. Or sure shot. What needs to happen to realize the full potential of AI in the fertility sector?

Quality healthcare requires two critical components: patients' best interests and best decisions to achieve that goal. The first goal is the lodestar, unchanged and unchanging over time. The second component is a more dynamic and rapidly changing paradigm in healthcare.

Legal personhood and frozen embryos: implications for fertility patients and providers in post- America.

The demise of has prompted some state lawmakers to try to redefine legal personhood to begin before birth and even before pregnancy. The sweeping abortion bans passed and pending in the wake of pose a threat to reproductive rights that extends beyond abortion. That threat spills over into in vitro fertilization (IVF) and other assisted reproductive technologies (ART).

Artificial intelligence and assisted reproductive technologies: 2023. Ready for prime time? Or not.

Artificial intelligence has transformed many aspects of health care from image analysis to clinical decision making. Its evolution in medicine has been gradual and deliberate with several unanswered questions regarding efficiency, privacy, and bias. These artificial intelligence-based tools have relevance to assisted reproductive technologies with opportunities to impact informed consent, day-to-day management of ovarian stimulation, oocyte and embryo selection, and workflow.